News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
275,275 Results
Type
Article (8126)
Company Profile (49)
Press Release (267098)
Multimedia
Podcasts (33)
Webinars (7)
Section
Business (70521)
Career Advice (299)
Deals (16651)
Drug Delivery (52)
Drug Development (18101)
Employer Resources (36)
FDA (6685)
Job Trends (6350)
News (114932)
Policy (10779)
Tag
Academia (769)
Accelerated approval (15)
Adcomms (4)
Allergies (60)
Alliances (19431)
ALS (33)
Alzheimer's disease (531)
Antibody-drug conjugate (ADC) (96)
Approvals (6997)
Artificial intelligence (272)
Autoimmune disease (46)
Automation (16)
Bankruptcy (121)
Best Places to Work (5698)
BIOSECURE Act (4)
Biosimilars (136)
Biotechnology (26)
Bladder cancer (63)
Brain cancer (20)
Breast cancer (241)
Cancer (1616)
Cardiovascular disease (174)
Career advice (276)
Career pathing (2)
CAR-T (68)
CDC (11)
Celiac Disease (1)
Cell therapy (197)
Cervical cancer (17)
Clinical research (16543)
Collaboration (670)
Compensation (125)
Complete response letters (13)
COVID-19 (860)
CRISPR (25)
C-suite (398)
Cystic fibrosis (36)
Data (2279)
Decentralized trials (1)
Denatured (12)
Depression (55)
Diabetes (194)
Diagnostics (3836)
Digital health (31)
Diversity (4)
Diversity, equity & inclusion (11)
Drug discovery (77)
Drug pricing (89)
Drug shortages (7)
Duchenne muscular dystrophy (82)
Earnings (25277)
Editorial (23)
Employer branding (2)
Employer resources (33)
Events (58010)
Executive appointments (495)
FDA (8163)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (3)
Frontotemporal dementia (10)
Funding (665)
Gene editing (52)
Generative AI (22)
Gene therapy (148)
GLP-1 (293)
Government (1550)
Grass and pollen (4)
Guidances (203)
Healthcare (9836)
HIV (34)
Huntington's disease (5)
IgA nephropathy (32)
Immunology and inflammation (53)
Immuno-oncology (15)
Indications (50)
Infectious disease (970)
Inflammatory bowel disease (74)
Inflation Reduction Act (7)
Influenza (42)
Intellectual property (92)
Interviews (38)
IPO (8313)
IRA (20)
Job creations (884)
Job search strategy (242)
JPM (58)
Kidney cancer (1)
Labor market (16)
Layoffs (95)
Leadership (3)
Legal (2402)
Liver cancer (22)
Longevity (4)
Lung cancer (199)
Lymphoma (130)
Machine learning (12)
Management (14)
Manufacturing (245)
MASH (75)
Medical device (7428)
Medtech (7460)
Mergers & acquisitions (9131)
Metabolic disorders (499)
Multiple sclerosis (89)
NASH (6)
Neurodegenerative disease (86)
Neuropsychiatric disorders (29)
Neuroscience (958)
Neurotech (1)
NextGen: Class of 2026 (3415)
Non-profit (1666)
Now hiring (4)
Obesity (220)
Opinion (91)
Ovarian cancer (53)
Pain (67)
Pancreatic cancer (79)
Parkinson's disease (77)
Partnered (14)
Patents (163)
Patient recruitment (149)
Peanut (20)
People (23586)
Pharmaceutical (13)
Pharmacy benefit managers (16)
Phase 1 (4130)
Phase 2 (6544)
Phase 3 (6887)
Pipeline (2422)
Policy (93)
Postmarket research (822)
Preclinical (1428)
Press Release (11)
Prostate cancer (96)
Psychedelics (10)
Radiopharmaceuticals (118)
Rare diseases (299)
Real estate (1840)
Recruiting (12)
Regulatory (8694)
Reports (21)
Research institute (751)
Resumes & cover letters (28)
Rett syndrome (18)
RNA editing (3)
RSV (35)
Schizophrenia (66)
Series A (112)
Series B (100)
Service/supplier (3)
Sickle cell disease (48)
Special edition (7)
Spinal muscular atrophy (45)
Sponsored (12)
Startups (1549)
State (1)
Stomach cancer (3)
Supply chain (39)
Tariffs (24)
The Weekly (21)
Vaccines (282)
Venture capital (45)
Weight loss (123)
Women's health (57)
Worklife (2)
Date
Today (80)
Last 7 days (333)
Last 30 days (1023)
Last 365 days (13188)
2026 (1957)
2025 (13494)
2024 (15063)
2023 (16973)
2022 (24396)
2021 (26529)
2020 (25914)
2019 (21239)
2018 (15859)
2017 (11950)
2016 (11875)
2015 (14382)
2014 (10412)
2013 (8607)
2012 (9074)
2011 (8733)
2010 (7255)
Location
Africa (253)
Alabama (25)
Alaska (1)
Arizona (132)
Arkansas (6)
Asia (14369)
Australia (1917)
California (4590)
Canada (1241)
China (391)
Colorado (251)
Connecticut (212)
Delaware (141)
Europe (32095)
Florida (753)
Georgia (159)
Hawaii (2)
Idaho (27)
Illinois (457)
India (51)
Indiana (270)
Iowa (2)
Japan (227)
Kansas (45)
Kentucky (25)
Louisiana (18)
Maine (73)
Maryland (586)
Massachusetts (3234)
Michigan (208)
Minnesota (289)
Mississippi (4)
Missouri (89)
Montana (8)
Nebraska (15)
Nevada (74)
New Hampshire (39)
New Jersey (1600)
New Mexico (9)
New York (1409)
North Carolina (800)
North Dakota (1)
Northern California (2207)
Ohio (164)
Oklahoma (7)
Oregon (15)
Pennsylvania (1153)
Puerto Rico (4)
Rhode Island (16)
South America (355)
South Carolina (28)
Southern California (1827)
Tennessee (127)
Texas (809)
United States (18000)
Utah (213)
Vermont (1)
Virginia (121)
Washington D.C. (31)
Washington State (318)
West Virginia (3)
Wisconsin (58)
Wyoming (1)
275,275 Results for "shionogi viiv healthcare llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ViiV Healthcare’s long-acting Cabenuva (cabotegravir + rilpivirine) for HIV demonstrates superior efficacy compared to daily oral therapy for people with adherence challenges; results published in NEJM
February 18, 2026
·
8 min read
Press Releases
ViiV Healthcare showcases long-acting HIV innovation and potential of ultra long-acting pipeline, including new data for first third-generation integrase inhibitor at CROI 2026
February 17, 2026
·
19 min read
Press Releases
ViiV Healthcare showcases breadth of clinical and real-world evidence at EACS and IDWeek 2025
October 10, 2025
·
20 min read
Press Releases
Tanabe Pharma America Announces Transfer of RADICAVA® Business to Shionogi
December 23, 2025
·
7 min read
Press Releases
Cumulus Neuroscience Enters Japanese Market to Advance Novel Cognitive Biomarkers with New Customer Shionogi & Co., Ltd.
February 10, 2026
·
4 min read
Press Releases
ViiV Healthcare announces 96-week data reaffirming Dovato is as effective as Biktarvy in maintaining virological suppression of HIV-1 with significantly less weight gain
October 20, 2025
·
13 min read
Press Releases
Shionogi Expands Rare Disease Presence with Planned Acquisition of Global Rights to Tanabe Pharma Corporation’s RADICAVA ORS® (edaravone) and IV RADICAVA
December 23, 2025
·
9 min read
Bio NC
ViiV Healthcare and The American Academy of HIV Medicine Announce Fellowship to Improve HIV Prevention in Key Communities
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, and the American Academy of HIV Medicine jointly announced the launch of The Dr. Dawn K. Smith HIV Prevention Clinical Fellowship.
March 5, 2024
·
6 min read
Press Releases
FDA Accepts Shionogi’s Ensitrelvir NDA as the First Oral Therapy for the Prevention of COVID-19 Following Exposure
September 3, 2025
·
9 min read
Press Releases
ViiV Healthcare presents new data demonstrating positive real-world impact of its innovative long-acting injectables for HIV at IAS 2025
July 9, 2025
·
15 min read
1 of 27,528
Next
